1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > IMS Pharmaceutical Pricing & Reimbursement Concise Guide: France

The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of the IMS pricing and reimbursement specialists to provide industry players and decision makers with a thorough understanding of the rules and regulations governing P&R in international markets. This report covers key developments in P&R, market access, cost containment, trade margins and healthcare issues.

Table Of Contents

IMS Pharmaceutical Pricing and Reimbursement Concise Guide: France
FRANCE .1
HEALTHCARE SYSTEM..1
Facts and Figures ..1
Market Indicators2
Provision and Funding ...5
Overview..5
Statutory Health Insurance System.5
Complementary Health Insurance...6
Funding7
Background..7
Healthcare Reform Law...8
PRICING...8
Prescription Drugs..8
Overview..9
Standard Pricing Procedure 9
Accelerated Pricing Procedure..10
Health Economic Evaluation..13
Conditional Pricing.13
Pricing Agreements ...14
Price Caps .16
Hepatitis C Drugs ..16
Price Levels ...16
Generic Drugs ..16
Pricing Rules..16
Pricing Procedure ..17
Hospital Drugs..17
T2A System ...17
T2A Exclusions and Liste de Retrocession ...17
ATU/post-ATU ...19
Actual Prices..19
OTC Drugs ...19
Reimbursed OTCs .19
Non-reimbursed OTCs ..19
REIMBURSEMENT 20
Admission to Reimbursement ..20
Patient Participation...20
Role of the CT20
Application Process ...21
Medical Benefit Rating Systems23
Assessment ...24
Decision.24
Final Decision 25
Restricted Reimbursement 25
Proposed New Evaluation System 26
Reimbursement Categories .26
Full Reimbursement ..26
Standard Reimbursement..26
Proposed Changes27
Reimbursement Prices.27
Reference Price Reimbursement System .27
Hospital Reimbursement..28
Hospital Supply Authorisation28
Formularies29
Funding..30
Changes in Reimbursement Status .33
Five-year Reviews .33
Exceptional Reviews .34
Changes to Reimbursed Indications .35
Reimbursement Rate Changes .35
Delistings ...36
Changes in Reimbursement Prices .36
European Price Guarantee36
Five-year Reviews .38
Off-patent Originals and Generics .39
Price Consistency..40
Targeted Price Cuts...40
Other Price Cuts/Revisions ...41
Price Increases..42
PHARMACOECONOMICS.42
Pharmacoeconomic Requirements..42
Mandatory HE Evaluations 42
Other HE Evaluations 45
PRICE BUILD UP ...45
Wholesalers .45
Margins ..45
Discounts ...46
Social Security Contribution ..46
Background47
Drug Shortages .47
Supply Chain Investigation 48
Retail Pharmacies 48
Margins ..48
Discounts ...50
Background50
Dispensing Doctors ..52
Sales Tax .52
COST CONTAINMENT ..52
Industry Paybacks52
Turnover-based Tax ..52
Clause de Sauvegarde ..52
Conventions System..54
Hepatitis C Medicines55
Temporary Use Drugs ...56
Promotional Costs56
Promotion-based Tax 56
Advertising.57
Sales Reps 58
Sunshine Act..58
Patient Co-payments58
Pharmaceuticals 58
Out-patient Care 60
In-patient Care...62
Prescribing Controls.63
Prescribing Targets ...63
Guidelines..64
Exception Drugs 64
Feedback ...64
Campaigns.65
Prescribing Restrictions.65
Off-label Prescribing ..65
Generics...66
National Action Plan ..66
Generic Substitution ..66
INN Prescribing .68
Prescribing Targets ...68
Generic and Off-patent Price Cuts 68
Biosimilars .69
Rx-to-OTC Switches 69
Switches 69
Easier Patient Access to OTCs .69
OTC Sales .69
Parallel Trade...70
Parallel Exports .70
Parallel Imports..70
FUTURE DEVELOPMENTS ..70
Outlook.70
LFSS 2017.70
Liste en Sus ...73
Generic Pricing ..73
Reimbursement Rates...73
Pharmacy Convention ...73
Accord Cadre.73
Proposed New Evaluation Systems ..74
NAMES and ADDRESSES 75

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Hospital Acquired Infection Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Hospital Acquired Infection Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • December 2016
  • by Transparency Market Research

Global Hospital Acquired Infection Treatment Market: Overview This report on hospital acquired infection treatment, studies the current as well as future prospects of the market globally. Hospital infections ...

Global Gene Therapy Partnering Terms and Agreements 2010 to 2016

Global Gene Therapy Partnering Terms and Agreements 2010 to 2016

  • $ 2995
  • Industry report
  • October 2016
  • by Currentpartnering

The Global Gene Therapy Partnering Agreements 2010-2016 report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies. ...

Gastrointestinal Bleeding (Gastrointestinal Hemorrhage) Global Clinical Trials Review, H2, 2016

Gastrointestinal Bleeding (Gastrointestinal Hemorrhage) Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • November 2016
  • by Global Data

Gastrointestinal Bleeding (Gastrointestinal Hemorrhage) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Gastrointestinal Bleeding (Gastrointestinal Hemorrhage) Global ...


Download Unlimited Documents from Trusted Public Sources

Cancer Statistics in Denmark

  • January 2017
    6 pages
  • Therapy  

  • Denmark  

View report >

Anti-Infective Market in India

  • January 2017
    4 pages
  • Anti-Infective  

    Blood Disease  

  • India  

    United States  

View report >

Insulin Market and Diabetes Statistics in the US

  • January 2017
    8 pages
  • Insulin  

    Antidiabetics  

    Diabetes  

  • United States  

View report >

Related Market Segments :

Hospital

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.